These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8769635)

  • 21. Immunogenicity, protective efficacy, and non-replicative status of the HSV-2 vaccine candidate HSV529 in mice and guinea pigs.
    Bernard MC; Barban V; Pradezynski F; de Montfort A; Ryall R; Caillet C; Londono-Hayes P
    PLoS One; 2015; 10(4):e0121518. PubMed ID: 25837802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonvirion antigens produced by herpes simplex viruses 1 and 2.
    Tarro G; Sabin AB
    Proc Natl Acad Sci U S A; 1973 Apr; 70(4):1032-6. PubMed ID: 4352219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant interleukin 2 as an adjuvant for vaccine-induced protection. Immunization of guinea pigs with herpes simplex virus subunit vaccines.
    Weinberg A; Merigan TC
    J Immunol; 1988 Jan; 140(1):294-9. PubMed ID: 2826591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of acquired resistance to herpes simplex virus infection as studied in nude mice.
    Nagafuchi S; Oda H; Mori R; Taniguchi T
    J Gen Virol; 1979 Sep; 44(3):715-23. PubMed ID: 231089
    [No Abstract]   [Full Text] [Related]  

  • 25. [Molecular mechanisms of herpes simplex virus infection].
    Kawaguchi Y
    Seikagaku; 2012 May; 84(5):343-51. PubMed ID: 22746056
    [No Abstract]   [Full Text] [Related]  

  • 26. Postexposure serum prophylaxis of neonatal herpes simplex virus infection of mice.
    Baron S; Worthington MG; Williams J; Gaines JW
    Nature; 1976 Jun; 261(5560):505-6. PubMed ID: 180414
    [No Abstract]   [Full Text] [Related]  

  • 27. The pathogenesis of acute, latent and recurrent herpes simplex virus infections.
    Klein RJ
    Arch Virol; 1982; 72(3):143-68. PubMed ID: 6180702
    [No Abstract]   [Full Text] [Related]  

  • 28. Protection of guinea pigs from primary and recurrent herpes simplex virus (HSV) type 2 cutaneous disease with vaccinia virus recombinants expressing HSV glycoprotein D.
    Wachsman M; Aurelian L; Smith CC; Lipinskas BR; Perkus ME; Paoletti E
    J Infect Dis; 1987 Jun; 155(6):1188-97. PubMed ID: 3033094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccination with recombinant herpes simplex virus glycoproteins: protection against initial and recurrent genital herpes.
    Stanberry LR; Bernstein DI; Burke RL; Pachl C; Myers MG
    J Infect Dis; 1987 May; 155(5):914-20. PubMed ID: 3031173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection against zosteriform spread of herpes simplex virus by monoclonal antibodies.
    Mester JC; Glorioso JC; Rouse BT
    J Infect Dis; 1991 Feb; 163(2):263-9. PubMed ID: 1846388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunity to tumors induced by herpes simplex virus in hamsters].
    Kosiakov PN; Posevaia TA; Kosiakova NP; Barinskiĭ IF
    Vopr Virusol; 1991; 36(1):40-4. PubMed ID: 1650065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protection of newborn mice from a lethal herpes simplex virus infection by human interferon, antibody, and leukocytes.
    Kohl S; Loo LS; Greenberg SB
    J Immunol; 1982 Mar; 128(3):1107-11. PubMed ID: 6173420
    [No Abstract]   [Full Text] [Related]  

  • 33. Repression of viral transcription during herpes simplex virus latency.
    Preston CM
    J Gen Virol; 2000 Jan; 81(Pt 1):1-19. PubMed ID: 10640537
    [No Abstract]   [Full Text] [Related]  

  • 34. Herpes simplex: evolving concepts.
    Pereira FA
    J Am Acad Dermatol; 1996 Oct; 35(4):503-20; quiz 521-2. PubMed ID: 8859276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Infections due to herpes simplex virus, recurrent disease and problem of latency].
    Terni M
    G Mal Infett Parassit; 1971 Jul; 23(7):433-67. PubMed ID: 4334706
    [No Abstract]   [Full Text] [Related]  

  • 36. [Suppressive therapy for genital herpes simplex virus infections].
    Sugase M
    Nihon Rinsho; 2006 Mar; 64 Suppl 3():316-20. PubMed ID: 16615491
    [No Abstract]   [Full Text] [Related]  

  • 37. [Experimental inner ear pathology with herpes simplex virus infection II. Intralabyrinthine inoculation of herpes simplex virus in guinea pigs].
    Koide J; Kurata T; Hondo R
    Nihon Jibiinkoka Gakkai Kaiho; 1982 Apr; 85(4):415-21. PubMed ID: 6288901
    [No Abstract]   [Full Text] [Related]  

  • 38. [Therapy of recurrent Herpes simplex].
    Söltz-Szöts J
    Z Haut Geschlechtskr; 1971 Apr; 46(8):267-72. PubMed ID: 4324186
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunotherapy and drugs in neonatal disseminated herpes simplex virus type 2 infections: a mouse model.
    Strulovitch C; Marks MI; Soneji A; Goldberg S
    J Antimicrob Chemother; 1979 Jul; 5(4):437-46. PubMed ID: 226512
    [No Abstract]   [Full Text] [Related]  

  • 40. Pathogenesis of herpes simplex labialis. I. Replication of herpes simplex virus in cultures of epidermal cells from subjects with frequent recurrences.
    Spruance SL; Chow FS
    J Infect Dis; 1980 Nov; 142(5):671-5. PubMed ID: 6257796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.